Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is be...

Phase 3 clinical trials of Covaxin by Bharat Biotech International Ltd (BBIL) and ICMR have demonstrated 100% efficacy against severe Covid...

“The tireless efforts of our scientists at ICMR and BBIL have resulted in a truly effective international vaccine of the highest standards ...

Talking to , Singh Deo said, "We are considering allowing Covaxin for those who wish to opt for it after the Government of India dropped th...

After more than two hours of deliberation on Wednesday, the SEC in its recommendation to the drug regulator asked for the removal of clinic...

The drug regulator’s subject expert committee (SEC) will meet on Thursday to consider the vaccine maker’s request and review the data. “The...

The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...

However, the report made it clear that efficacy cannot be determined by phase 2 trials and this required further corroboration with phase 3...

Bharat Biotech's indigenously developed Covid-19 vaccine, Covaxin, was well tolerated and did not report any serious adverse events during ...

ET rounds up facts and some questions on Covishield and Covaxin, approved by DCGI on Sunday

The approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...

The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the countrys first an...

In a double-blind, randomised, multi-centre phase 2 clinical trials, a total of 380 healthy children and adults were randomised and adminis...

The rollout of the Covid-19 vaccine by Bharat Biotech for the general public may get delayed as the All India Institute of Medical Sciences...

Hyderabad-based Bharat Biotech is considering expanding phase-III trial of its Covid-19 vaccine candidate Covaxin by adding more sites to t...

The regulator’s subject expert committee met on Tuesday and approved the phase-3 trial of the company’s indigenously developed vaccine cand...

Human trials of Covaxin, India's first vaccine candidate against coronavirus, began at PGI Rohtak on July 17. Three volunteers were adminis...